Novo Nordisk A S 20-F for FY2023
Novo Nordisk A S (NVO)
20-F
2024-01-31
For: 2023-12-31
View Original
Added on
April 09, 2026
About this 20-F
Novo Nordisk A S filed this 20-F on January 31, 2024, covering the fiscal year ended December 31, 2023 (FY2023).
Headline figures
Fiscal year ended December 31, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- 232.26B DKK
- up 31.3% from 176.95B DKK a year earlier
- Net income
- 83.68B DKK
- up 50.7% from net income of 55.53B DKK a year earlier
- Diluted EPS
- 18.62 DKK
- up 52.4% from 12.22 DKK a year earlier